Family Wellness Ear Relief Ear Drops

The dosage of Matricaria Chamomilla varies significantly based on the intended use (diagnostic vs. therapeutic) and the specific formulation used.

Allergy Testing and Immunotherapy

For diagnostic skin prick testing, a concentration of 1:10 or 1:20 (weight/volume) is typically used. For immunotherapy, the dose is highly individualized. It begins with a very dilute 'starter' dose (e.g., 0.1 mL of a 1:100,000 dilution) and is gradually increased over several months to a maintenance dose, which may range from 0.5 mL of a 1:100 or 1:10 dilution, depending on patient tolerance and clinical response.

Oral Supplementation

For general health purposes, the standard adult dose of dried chamomile flower heads is 220 mg to 1,600 mg daily, often divided into two or three doses. If using a standardized extract (containing 1.2% apigenin), a common dose is 400 mg to 800 mg once daily.

Matricaria Chamomilla has been studied in children for conditions like infantile colic and diarrhea, but its use as an allergenic extract in children requires extreme caution.

• Infantile Colic: Clinical trials have used a specific herbal tea containing chamomile at doses of approximately 150 mL per day, administered in small increments.
• Allergy Testing: Pediatric skin testing should only be performed by a specialist. Doses are generally similar to adult concentrations, but the number of tests performed at one time may be limited to prevent systemic reactions.

Renal Impairment

There are no specific dosage adjustments provided in the manufacturer's labeling for patients with renal impairment. However, because metabolites are excreted renally, patients with Stage 4 or 5 Chronic Kidney Disease (CKD) should be monitored for increased sedation or GI upset.

Hepatic Impairment

Since the liver is the primary site for the metabolism of chamomile's flavonoids and terpenoids, patients with severe hepatic impairment (Child-Pugh Class C) should use lower doses of oral supplements to avoid potential accumulation and toxicity.

Elderly Patients

Elderly patients may be more sensitive to the sedative effects of Matricaria Chamomilla. It is recommended to start at the lower end of the dosing range (e.g., 220 mg daily) to assess tolerance and minimize the risk of falls or cognitive impairment.

• Immunotherapy: These injections MUST be administered by a healthcare professional in a clinical setting equipped with emergency resuscitation equipment (epinephrine). Patients must remain in the office for at least 30 minutes following the injection.
• Oral Forms: Capsules and tablets should be taken with a full glass of water. They can be taken with or without food, though taking them with food may reduce the risk of mild stomach upset.
• Tea/Infusion: Steep 1-2 teaspoons of dried flowers in hot water for 10-15 minutes. Ensure the container is covered to prevent the volatile essential oils from escaping.
• Storage: Store all forms in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

If you miss a dose of an oral supplement, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up. If you miss an immunotherapy injection, contact your allergist immediately; your dosing schedule may need to be adjusted or 're-started' at a lower concentration to ensure safety.

Signs of an overdose of Matricaria Chamomilla may include severe nausea, vomiting, dizziness, and extreme drowsiness. In the case of an immunotherapy overdose, the primary risk is anaphylaxis (a life-threatening allergic reaction). Symptoms of anaphylaxis include swelling of the throat, difficulty breathing, a rapid drop in blood pressure, and hives. If an overdose is suspected, seek emergency medical attention or contact a poison control center immediately.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

Matricaria Chamomilla is generally well-tolerated, but some individuals may experience mild adverse effects, particularly when starting therapy. Common side effects include:

• Mild Sedation: A feeling of relaxation or sleepiness that typically lasts 2-4 hours after ingestion.
• Gastrointestinal Upset: Mild nausea or abdominal cramping, especially when taken on an empty stomach.
• Contact Dermatitis: When applied topically, some users may experience redness, itching, or a mild rash at the site of application.

• Dizziness: A sensation of lightheadedness or vertigo, which may be exacerbated if taken with other sedatives.
• Ocular Irritation: If chamomile vapors or extracts come into contact with the eyes, they can cause significant watering, redness, and stinging.
• Increased Sensitivity: Some patients may find they become more sensitive to sunlight (photosensitivity) while using high doses of chamomile extracts.

• Severe Vomiting: High concentrations of the extract can act as an emetic in sensitive individuals.
• Paradoxical Excitation: In rare cases, especially in children or the elderly, chamomile may cause restlessness or insomnia instead of sedation.
• Bronchospasm: Inhalation of chamomile pollen or vapors may trigger an asthma attack in predisposed individuals.

> Warning: Stop taking Matricaria Chamomilla and call your doctor immediately if you experience any of these.

• Anaphylaxis: This is the most serious risk associated with Matricaria Chamomilla, particularly in individuals with known allergies to the Asteraceae family (e.g., ragweed, daisies, marigolds). Symptoms include swelling of the face, tongue, or throat; difficulty swallowing; wheezing; and a rapid, weak pulse.
• Severe Skin Reactions: Disseminated urticaria (hives) or angioedema (deep tissue swelling) requiring systemic corticosteroid treatment.
• Hypotension: A significant drop in blood pressure that may cause fainting or syncope.
• Respiratory Distress: Acute shortness of breath or chest tightness following the administration of an allergenic extract.

Prolonged use of Matricaria Chamomilla is generally considered safe; however, there are considerations for long-term therapy:

1. 1Sensitization: Continuous exposure to the plant extract can, in rare instances, lead to the development of a new allergy where none existed before.
2. 2Hormonal Effects: Some studies suggest that chamomile may have weak estrogenic activity. While the clinical significance is unclear, long-term use in patients with hormone-sensitive conditions (like breast cancer) should be discussed with an oncologist.
3. 3Tolerance: While not common, some patients report a diminishing sedative effect over several months of nightly use, suggesting a mild pharmacological tolerance.

No FDA black box warnings currently exist for Matricaria Chamomilla as a botanical supplement. However, for Allergenic Extracts as a class, the FDA requires prominent warnings regarding the risk of severe systemic reactions, including anaphylaxis. These extracts must only be administered in settings where emergency medical care is immediately available.

Report any unusual symptoms to your healthcare provider. Monitoring for signs of allergic progression is essential during the first several weeks of use.

Matricaria Chamomilla, while natural, is a potent pharmacological agent that requires careful handling. The most critical safety concern is the potential for cross-reactivity. If you are allergic to ragweed, chrysanthemums, marigolds, or daisies, you are at a significantly higher risk of a severe allergic reaction to chamomile. Always inform your healthcare provider of your full allergy profile before using this substance.

There are no specific FDA black box warnings for Matricaria Chamomilla flower products. However, if the product is being used as part of a Standardized or Non-Standardized Allergenic Extract injection, it carries a general class warning: "This product may cause severe life-threatening systemic reactions, including anaphylactic shock. Patients should be observed for at least 30 minutes after injection, and epinephrine must be available."

Allergic Reactions / Anaphylaxis Risk

Matricaria Chamomilla contains several proteins that can trigger IgE-mediated hypersensitivity. Anaphylaxis has been reported following the ingestion of chamomile tea and the use of chamomile-containing enemas. Patients with a history of severe asthma are at increased risk for more severe reactions during allergen immunotherapy.

Organ-Specific Risks

• Hepatotoxicity: While chamomile is not typically hepatotoxic, it can interact with other medications that stress the liver. Patients with pre-existing liver disease should use it with caution.
• Coagulopathy: Chamomile contains natural coumarin compounds. While the concentration is usually low, there is a theoretical risk of increased bleeding, especially in patients already taking anticoagulants like warfarin or aspirin.

QT Prolongation

There is currently no evidence that Matricaria Chamomilla causes QT prolongation or significant cardiac arrhythmias at standard doses. However, its interaction with the adrenergic system suggests that patients with unstable arrhythmias should use it only under medical supervision.

For patients undergoing allergen immunotherapy with Matricaria Chamomilla extracts, the following monitoring is required:

• Post-Injection Observation: 30-minute mandatory wait time in the clinic.
• Lung Function: Peak flow or spirometry may be checked before injection in asthmatic patients.
• Skin Assessment: Monitoring for localized swelling or systemic hives.
• Liver Function Tests (LFTs): May be recommended if high-dose oral therapy is used long-term in conjunction with other supplements.

Because Matricaria Chamomilla can cause significant drowsiness and sedation, patients should avoid driving, operating heavy machinery, or engaging in hazardous activities until they know how the substance affects them. This is particularly important when combining chamomile with alcohol or other CNS depressants.

Alcohol can significantly potentiate (increase) the sedative effects of Matricaria Chamomilla. Combining the two can lead to excessive respiratory depression, impaired coordination, and increased risk of accidents. It is advised to limit or avoid alcohol consumption while using chamomile therapeutically.

There is no evidence of a physical withdrawal syndrome associated with the discontinuation of Matricaria Chamomilla. However, if used for chronic insomnia or anxiety, symptoms may return (rebound) upon stopping. For immunotherapy, stopping the injections abruptly will result in a loss of desensitization, and the process may need to be restarted from the beginning if therapy is resumed later.

> Important: Discuss all your medical conditions with your healthcare provider before starting Matricaria Chamomilla.

While there are no absolute contraindications with specific drugs that are universally 'banned,' the following combination is considered highly dangerous:

• Cyclosoporine and High-Dose Chamomile: There is a theoretical risk that chamomile's inhibition of CYP3A4 could lead to toxic levels of cyclosporine, potentially causing severe kidney damage or immunosuppression-related infections.

• Warfarin (Coumadin): Chamomile contains coumarin derivatives which may have additive effects with warfarin. This can lead to an increased International Normalized Ratio (INR) and a higher risk of internal bleeding. Patients on warfarin must have their INR monitored more frequently if starting or stopping chamomile.
• Benzodiazepines (e.g., Alprazolam, Diazepam): Since apigenin in chamomile binds to the same receptors as benzodiazepines, the combination can cause profound sedation, respiratory depression, and cognitive impairment.
• Sedative-Hypnotics (e.g., Zolpidem, Eszopiclone): Similar to benzodiazepines, the additive sedative effect can be dangerous, particularly in the elderly.

• Antihypertensive Drugs: Matricaria Chamomilla may have mild blood-pressure-lowering effects. When taken with ACE inhibitors or beta-blockers, it may cause hypotension (excessively low blood pressure).
• Diabetes Medications: Some evidence suggests chamomile may lower blood sugar. Monitoring for hypoglycemia (low blood sugar) is recommended when combined with insulin or sulfonylureas.
• CYP3A4 Substrates: Chamomile inhibits the CYP3A4 enzyme. Drugs like fexofenadine, statins (lovastatin, atorvastatin), and certain anti-retrovirals may see increased serum concentrations.

• Alcohol: As noted, alcohol significantly increases the sedative properties of chamomile.
• Iron-Rich Foods: Chamomile contains polyphenols that can bind to non-heme iron (the type found in plants and supplements), reducing its absorption. It is best to take chamomile at least two hours apart from iron supplements or iron-rich meals.

• St. John’s Wort: May increase the risk of photosensitivity when combined with chamomile.
• Valerian, Kava, and Melatonin: These all have sedative properties and will work synergistically with chamomile to increase sleepiness.
• Garlic, Ginkgo, and Saw Palmetto: These supplements also have mild anti-platelet effects and may further increase the risk of bleeding when taken with chamomile.

• Skin Allergy Tests: If you are taking oral chamomile supplements, they may interfere with the results of skin prick tests for other allergens, potentially causing a false-negative result. Discontinue oral chamomile at least 3-5 days before allergy testing.
• Coagulation Panels: As mentioned, PT/INR results may be affected.

For each major interaction, the management strategy usually involves dose adjustment of the primary medication or spacing the administration of the two substances. Always consult a pharmacist to check for specific drug-herb interactions.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

Matricaria Chamomilla must NEVER be used in the following circumstances:

• Severe Hypersensitivity: Any patient with a documented history of anaphylaxis or severe systemic allergic reactions to chamomile or any member of the Asteraceae/Compositae family (ragweed, sunflowers, daisies, etc.) must avoid all forms of this ingredient.
• Uncontrolled Asthma: For patients undergoing allergen immunotherapy, having uncontrolled or severe asthma is an absolute contraindication due to the high risk of a fatal respiratory reaction during treatment.
• Active Denuded Skin: Topical chamomile should not be applied to large areas of broken, weeping, or severely denuded skin, as this can lead to rapid systemic absorption and sensitization.

Conditions requiring a careful risk-benefit analysis include:

• Pregnancy (High Doses): While occasional tea is likely safe, high-dose chamomile extracts are relatively contraindicated due to their historical use as an abortifacient (a substance that induces abortion) and uterine stimulant.
• Hormone-Sensitive Conditions: Patients with breast, uterine, or ovarian cancer should use chamomile cautiously due to its potential phytoestrogenic activity.
• Pre-Surgery: Because of the potential for increased bleeding and interactions with anesthesia, chamomile should be discontinued at least 2 weeks before elective surgical procedures.

Cross-sensitivity is a major clinical concern with Matricaria Chamomilla. If you are allergic to any of the following, you are likely cross-sensitive to chamomile:

• Ragweed (Ambrosia)
• Chrysanthemums
• Marigolds
• Daisies
• Arnica
• Echinacea

> Important: Your healthcare provider will evaluate your complete medical history before prescribing or recommending Matricaria Chamomilla.

Matricaria Chamomilla is generally classified as FDA Pregnancy Category C (or considered 'Use with Caution' in herbal monographs). There is insufficient high-quality clinical data to rule out risks to the fetus. Historically, chamomile has been used in high doses to stimulate the uterus and induce menstruation, which poses a theoretical risk of miscarriage or preterm labor. However, the occasional consumption of chamomile tea is generally regarded as safe by most obstetricians. Pregnant women should avoid concentrated extracts or essential oils unless specifically directed by their physician.

Components of Matricaria Chamomilla, including its essential oils and flavonoids, likely pass into breast milk in small amounts. While there are no documented cases of toxicity in nursing infants, chamomile's sedative effects could theoretically cause lethargy in the baby. Mothers should monitor their infants for unusual sleepiness or poor feeding if they are consuming large amounts of chamomile.

Chamomile is frequently used in pediatric populations for colic, teething, and diarrhea. However, the risk of developing an allergy is a concern.

• Infants < 6 months: Should not be given chamomile without direct medical supervision.
• Botulism Risk: There is a very rare but serious risk of botulism spores being present in raw dried herbs. For this reason, some experts advise against giving chamomile tea to infants under 12 months old.
• Allergy: Children with eczema or other atopic conditions are at higher risk of developing a chamomile allergy.

In patients over age 65, the primary concerns are polypharmacy and fall risk. Because the elderly often take multiple medications (e.g., blood thinners, blood pressure meds), the risk of drug interactions is significantly higher. Additionally, the sedative effect of chamomile can contribute to nighttime confusion (sundowning) and increase the risk of falls and fractures. Lower doses are recommended for this population.

In patients with impaired kidney function, the clearance of chamomile metabolites may be delayed. While no specific GFR-based (Glomerular Filtration Rate) dosing exists, clinicians should monitor for signs of accumulation, such as persistent dizziness or gastrointestinal distress. Chamomile is not known to be cleared by hemodialysis.

Patients with liver cirrhosis or hepatitis may have a reduced capacity to metabolize the flavonoids in Matricaria Chamomilla. This can lead to higher systemic levels and an increased risk of side effects. Use with caution in patients with a Child-Pugh score of B or C.

> Important: Special populations require individualized medical assessment to ensure safety and efficacy.

Matricaria Chamomilla exerts its effects through a complex interplay of phytochemicals. The primary mechanism for its sedative effect is the binding of apigenin to central GABA-A receptors in the brain, which enhances inhibitory neurotransmission. Unlike benzodiazepines, apigenin does not seem to cause significant muscle relaxation.

Its anti-inflammatory action is mediated by chamazulene and alpha-bisabolol, which inhibit the 5-lipoxygenase and cyclooxygenase-2 (COX-2) pathways. Additionally, the extract shows Ammonium Ion Binding Activity [MoA], which may play a role in its metabolic effects. The Adrenergic alpha and beta-agonist activities suggest a role in modulating smooth muscle tone in the vasculature and bronchi.

• Onset of Action: Oral sedation typically begins within 30 to 60 minutes. Topical anti-inflammatory effects may be seen within 1-2 hours.
• Duration: The effects of a single oral dose generally last for 4 to 6 hours.
• Tolerance: Minimal risk of physical dependence, though psychological reliance for sleep may occur.

| Parameter | Value |

|---|---|

| Bioavailability | ~10-15% (Oral) |

| Protein Binding | High (~90% for Apigenin) |

| Half-life | 2 - 5 hours |

| Tmax | 1.5 - 2 hours |

| Metabolism | Hepatic (CYP3A4, Glucuronidation) |

| Excretion | Renal (70%), Fecal (25%) |

• Molecular Formula: C15H10O5 (Apigenin)
• Molecular Weight: 270.24 g/mol (Apigenin)
• Solubility: Essential oils are lipid-soluble; flavonoids are sparingly soluble in water but soluble in ethanol.
• Structure: A complex mixture of sesquiterpenes, flavonoids, and coumarins.

Matricaria Chamomilla belongs to the Non-Standardized Plant Allergenic Extract [EPC] class. It is also categorized as a botanical sedative and anti-inflammatory agent. Related medications in the allergenic extract class include Ragweed Pollen and Grass Pollen extracts.